Featured Research

from universities, journals, and other organizations

Is Rheumatoid Arthritis Becoming Milder?

Date:
September 3, 2005
Source:
John Wiley & Sons, Inc.
Summary:
Is the course of rheumatoid arthritis becoming milder? If so, why? Intrigued by these questions, researchers in The Netherlands decided to seek out the answers through a rigorous investigation.

Rheumatoid arthritis (RA) is a chronic inflammatory disease, markedwith joint pain and erosion. The course of RA can vary considerably,from mild to crippling, and is difficult to predict. On the strength ofpatient case histories and clinical trials, rheumatologists havesuggested that the majority of today's RA patients are suffering lesssevere symptoms and less functional disability compared with RApatients in past decades.

Is the course of RA becoming milder? If so, why? Intrigued by thesequestions, researchers in The Netherlands decided to seek out theanswers through a rigorous investigation. Published in the September2005 issue of Arthritis & Rheumatism (http://www.interscience.wiley.com/journal/arthritis),their findings indicate a positive trend. "Patients with early RApresenting in recent years have less severe disease activity atpresentation, as well as a more favorable course of their disease,compared with patients in earlier years," states the study's leadingauthor, Paco M. J. Welsing, MSc.

What is the reason for this improving trend? Welsing and his colleaguesfound no clear, conclusive cause, and even uncovered some contradictoryevidence. However, the team found a concurrent tendency toward ashorter duration of symptoms at the time of diagnosis and moreaggressive use of drug therapy--for instance, methotrexate, today'spreferred disease-modifying anti-rheumatic drug (DMARD) and/orprednisone--over the course of the disease.

The study included all newly diagnosed, early RA patientsenrolled in the department of rheumatology clinic of Radboud UniversityNijmegen Medical Centre since 1985. Patients were divided into fourgroups based on the date of enrollment. Patients enrolled between 1985and 1990 (167 total) comprised Group 1. Patients enrolled between 1990and 1995 (132 total) comprised Group 2. Patients enrolled between 1995and 2000 (114 total) comprised Group 3. And patients enrolled between2000 and 2005 (112 total) comprised Group 4. In all groups, themajority of patients were women. The mean age at the time of enrollmentwas 54 years for Group 1; 55 years for both Groups 2 and 3; and 57years for group 4.

Researchers set out to compare disease activity and functionaldisability among the groups over a 5-year progression (but 4-years,maximum, for Group 4). They also compared treatment strategies amongthe groups. All patients were assessed for signs of RAactivity--namely, swelling and tenderness--in 28 joints every 3 months,a laboratory measure for inflammation and a measure of general wellbeing by the Disease Activity Score 28 (DAS28). All patients wereassessed for functional disability--covering difficulties with walkingand conducting everyday activities--using the Health AssessmentQuestionnaire disability index (HAQ DI) every 6 months. In addition,all patients were periodically evaluated for pain in general.

The DAS28 scores at baseline and over the course of the studywere consistently lower, indicating milder disease activity, in themore recent groups--that is, patients diagnosed with RA within the lastten years. At the 5-year culmination, the DAS28 scores were lowest inthe most recent, complete group--Group 3, patients diagnosed between1995 and 2000--compared with both Group 2 (1990-1995) and Group 1(1985-1990). The average disease activity over time per patient showedsimilar trends of improvement. The average DAS28 score improved from4.1 to 3.4 from the Group 1 to Group 3.

However, the HAQ DI scores at baseline and over time were notlower among patients enrolled later in the study, and even showed someevidence of a worsening trend. "This contradictory result may be partlya distinction between measures of physical examination, laboratoryresults, and patient-assessed outcomes," notes Welsing, "which can beinfluenced by internal standards or attitudes of patients."

Researchers did find a correlation between more aggressivetreatment strategies and milder disease activity in the more recentgroups of patients. While suggesting the effectiveness of earlytreatment with methotrexate, for instance, and/or prednisone formanaging RA's symptoms and destructive progression, this connectioncalls for further investigation.

###

Article: "Is the DiseaseCourse of Rheumatoid Arthritis Becoming Milder? Time Trends Since 1985in an Inception Cohort of Early Rheumatoid Arthritis," Paco M. J.Welsing, Jaap Fransen, and Piet L. C. M. van Riel, Arthritis &Rheumatism, September 2005; 52:9; pp. 2616-2624.


Story Source:

The above story is based on materials provided by John Wiley & Sons, Inc.. Note: Materials may be edited for content and length.


Cite This Page:

John Wiley & Sons, Inc.. "Is Rheumatoid Arthritis Becoming Milder?." ScienceDaily. ScienceDaily, 3 September 2005. <www.sciencedaily.com/releases/2005/09/050902065747.htm>.
John Wiley & Sons, Inc.. (2005, September 3). Is Rheumatoid Arthritis Becoming Milder?. ScienceDaily. Retrieved September 18, 2014 from www.sciencedaily.com/releases/2005/09/050902065747.htm
John Wiley & Sons, Inc.. "Is Rheumatoid Arthritis Becoming Milder?." ScienceDaily. www.sciencedaily.com/releases/2005/09/050902065747.htm (accessed September 18, 2014).

Share This



More Health & Medicine News

Thursday, September 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Artificial Sweetener Could Promote Diabetes

Artificial Sweetener Could Promote Diabetes

Newsy (Sep. 17, 2014) Doctors once thought artificial sweeteners lacked the health risks of sugar, but a new study says they can impact blood sugar levels the same way. Video provided by Newsy
Powered by NewsLook.com
Ebola Vaccine Trial Gets Underway at Oxford University

Ebola Vaccine Trial Gets Underway at Oxford University

AFP (Sep. 17, 2014) A healthy British volunteer is to become the first person to receive a new vaccine for the Ebola virus after US President Barack Obama called for action against the epidemic and warned it was "spiralling out of control." Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Obesity Rates Steady Even As Americans' Waistlines Expand

Obesity Rates Steady Even As Americans' Waistlines Expand

Newsy (Sep. 17, 2014) Researchers are puzzled as to why obesity rates remain relatively stable as average waistlines continue to expand. Video provided by Newsy
Powered by NewsLook.com
President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins